ClinConnect ClinConnect Logo
Search / Trial NCT05964855

Comparison of Various Prosthetic Foot-Ankle Mechanisms

Launched by MASSACHUSETTS INSTITUTE OF TECHNOLOGY · Jul 19, 2023

Trial Information

Current as of November 11, 2025

Enrolling by invitation

Keywords

Foot Ankle Device Prosthesis Mobility

ClinConnect Summary

MIT is running a study to compare several foot-and-ankle prosthetic devices for people who have had one below-knee amputation. About 10 adults (ages 18–65) who are fairly mobile (Medicare levels K3 or K4) will try five devices—three passive (non-powered) and two powered—while researchers measure how they walk. The goal is to see which device people prefer for level walking, climbing stairs, and walking on a gentle slope, and to compare how each device changes walking patterns.

If you participate, you’ll complete two lab sessions totaling about 8 hours. A prosthetist will fit and align the devices, and you’ll practice with them before data are collected. Researchers will use cameras and force sensors to analyze your gait and you’ll answer short questionnaires after trying the devices. All five devices will be tested in random order. Some devices are experimental or not yet fully approved. The study began in 2023 and is currently enrolling by invitation, with completion expected by the end of 2025.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Person with unilateral transtibial amputation
  • K3 or K4 Medicare mobility rating
  • Ages 18-65
  • Exclusion Criteria:
  • Below K3 Medicare mobility rating
  • Outside of age range (liability and safety reasons)

About Massachusetts Institute Of Technology

The Massachusetts Institute of Technology (MIT) is a prestigious research university located in Cambridge, Massachusetts, renowned for its cutting-edge contributions to science, technology, and engineering. As a clinical trial sponsor, MIT leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical research and innovation. The institution is committed to fostering collaboration between academic, industry, and clinical partners, aiming to translate groundbreaking research into practical healthcare solutions. MIT's rigorous approach to clinical trials ensures the highest standards of scientific integrity and patient safety, positioning it as a leader in the pursuit of transformative therapies and medical advancements.

Locations

Cambridge, Massachusetts, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported